Gilead Sciences Inc said on Tuesday it expects the number of hepatitis C patients treated in Europe with its Sovaldi drug to increase dramatically this year, and that approvals for the newer combination pill, Harvoni, could come quickly. Read more here bit.ly/1A0aAZA
Gilead expects big increase in Europe... - HFI Connect - Hep...
Gilead expects big increase in Europeans treated with hep C drug
Written by
mwright
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Just found out I have Hep B and have red spots all over is that normal.
Hello everyone, I recently went to the doctors for food poisoning and found out I have typhiod and...
Overwhelmed
Hi everyone, I'm new to this site and really just looking for somewhere I can talk to people that...
